What is DT's health score?

Dynatrace, Inc. (DT) has a TradeApes health score of 50 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is DT's estimated fair value?

Based on our 5-year discounted cash flow model, Dynatrace, Inc.'s estimated fair value is $6.17 per share, representing a -85.5% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is DT undervalued or overvalued?

Our model currently rates DT as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for DT... Refresh in a moment for the full analysis.

Dynatrace, Inc. (DT)

Technology Overvalued low mixed

$42.59

Updated: 2026-05-30

TradeApes Score

Financial Strength

85 Strong

Operating Trend

38 Weak

Relative Value

30 Weak

Capital Allocation

30 Weak

Risk

70 Healthy

Est. Fair Value $6.17

DCF Upside -85.5%

Sector Rank #550 of 7729

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.